Literature DB >> 339075

Mutagenicity of hydroxamic acids for Salmonella typhimurium.

C Y Wang.   

Abstract

P-Butoxyphenylacethydroxamic acid, benzohydroxamic acid, salicylhydroxamic acid, 2-naphthohydroxamic acid, indole-2-carbohydroxamic acid and benzoylaminoacethydroxamic acid were synthesized, and their mutagenicity for Salmonella typhimurium strains TA98 and TA100 were determined. Except for p-butoxyphenylacethydroxamic acid, all the hydroxamic acids were mutagenic for both strains. The mutagenicity progressed in the following order: 2-naphthohydroxamic acid greater than benzohydroxamic acid and salicylhydroxamic acid greater than benzoylaminoacethydroxamic acid and indole-2-carbohydroxamic acid. The starting materials for the synthesis of these acids including hydroxylamine were not in themselves mutagenic for TA98 and TA100. Thus, while the mutagenicity may require the hydroxamic acid as a whole, the acyl group may determine the mutagenic potency.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339075     DOI: 10.1016/0027-5107(77)90235-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Mutagenicity of new lead compounds to treat sickle cell disease symptoms in a Salmonella/microsome assay.

Authors:  Jean Leandro dos Santos; Eliana A Varanda; Lídia Moreira Lima; Chung Man Chin
Journal:  Int J Mol Sci       Date:  2010-02-25       Impact factor: 5.923

2.  S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.

Authors:  M Ben Amar; G L'Espérance; R Tawashi
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

3.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

Authors:  Sida Shen; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-25       Impact factor: 3.466

Review 4.  A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019).

Authors:  Sida Shen; Alan P Kozikowski
Journal:  Expert Opin Ther Pat       Date:  2019-12-25       Impact factor: 6.674

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.